For pelvic-floor therapists & their teams
Bring adaptable device options into a therapist-led conversation about pelvic pain, sexual comfort and home use. Explore the research, compare individual fit and build a practical route from your consultation to the patient’s own routine.
Start with the person, not a protocol
The most useful question is where a device may fit within this patient’s goals and existing care. Education, therapeutic exercise, dilator work and psychosexual support remain distinct parts of the clinical picture.
Research relevant to the conversation
Review the Crescendo-family pain research and the Poco adjunct pilot when painful penetration or vaginismus is part of the clinical question. Keep the role of the combined care in view.
Patient-defined priorities
The randomized trial studied sexual function in women with pelvic-floor disorders. Discuss comfort, arousal, lubrication or orgasm in the patient’s own terms, alongside the goals of therapy.
Consent, comfort and individual fit
Compare shape, contact, handling and controls. A patient may prefer external use, a different profile or no device. Agree what feels manageable before developing the home-use plan.
Three useful starting points
These studies answer different questions: sexual function, acceptability as an adjunct and pain-related outcomes. FSFI is the Female Sexual Function Index; higher pain-domain scores indicate less pain, not a percentage reduction in pain.
Randomized controlled trial / 2026
84randomized · 81 completed · 8 weeks
Device use plus an educational handout was compared with the handout alone. Mean total FSFI scores at eight weeks were 22.2 versus 16.3, favoring the device group.
Single-center, unblinded trial. MV Health identifies the model as Poco; the accessible abstract does not name it. MysteryVibe is listed among funding sources. Published online August 27, 2026.
Controlled feasibility pilot / 2025 online
19analyzed · 30 enrolled · 6+ months
A non-randomized pilot added external Poco use to usual psychosexual care, including dilators. Nine of ten participants in the device group rated it mostly or completely acceptable.
Ten intervention and nine control participants were analyzed. Small groups, attrition and combined care limit efficacy conclusions. This is evidence about an adjunct, not a comparison with pelvic-floor therapy.
Conference abstract / 2022
11completed · 21 recruited · 12 weeks
Completers used the earlier Crescendo Therapy System with education and exercises. Mean FSFI pain-domain scores increased from 0.40 to 2.32 after twelve weeks.
Uncontrolled study with substantial attrition and industry funding. The studied system was not specifically Crescendo 2. The score change should not be described as a fivefold reduction in pain.
Fit is an individual conversation
Poco, Crescendo 2 and Molto offer different profiles. Compare the exact model’s instructions, intended use and controls before considering its place in a care plan. Form factor and treatment evidence are separate questions.
Compact profile / Adaptable shape
A compact, bendable design for a conversation about contact and positioning. The controlled vaginismus pilot evaluated external use alongside usual care, including dilators.
A useful evidence-review starting point for teams considering patient-controlled home use as an adjunct.
Flexible design / Adjustable positioning
An adaptable shape with multiple stimulation points, offering options for individual positioning and handling.
Review Crescendo-family pain research separately from Crescendo 2 studies. Evidence from an earlier model is not automatically evidence for the current generation.
Slim profile / Bendable format
A slim, bendable format to compare when a patient prefers a narrower device. Review the model-specific instructions and suitability with the treating therapist.
Included here for the choice of profile—not as an equivalent to Poco’s controlled research or a proven treatment for pelvic-floor dysfunction.
From the appointment to everyday use
A clear explanation, the right guide and an agreed follow-up help patients understand what to do next. Set the plan around clinical need rather than a universal device protocol.
Establish the patient’s priorities, relevant history and assessment findings. Agree the role, if any, of a device alongside other care and any referral needed.
Compare the exact model and controls. Discuss contact, positioning and consent. Use the current model guide to explain setup, cleaning, precautions and when to seek advice.
Provide a patient-specific plan and a clear product-support route. Check practical understanding and make the purchase price, seller and delivery arrangements clear.
Review comfort, actual use and progress toward the patient’s goals. Choose an appropriate outcome measure; address difficulties and adapt or stop the plan when clinically indicated.
For owners and practice managers
Separate the clinical service, the device purchase and any monitoring program. That makes responsibilities and costs easier for your team and patients to understand.
01 / Clinic purchasing
Request a current quote for the models and quantities your team wants to offer. Agree ordering, delivery, patient pricing, returns and after-purchase support.
Build the business case from your written quote, actual costs and proposed workflow.
02 / Access without clinic stock
If you prefer not to hold stock, discuss the available direct-purchase arrangements. Give the patient a clear route to the correct model and product guidance.
Agree any referral relationship, disclosures and support responsibilities before introducing it.
03 / Optional, separately assessed RTM
Add supported check-ins between visits for appropriate patients in a defined pelvic-health care plan. HealthArc is an available operating program, subject to practice and patient review.
MV.Health supplies the selected device. HealthArc supports enrollment, patient-reported check-ins, care management and documentation. Your practice retains the care plan, clinical oversight and responsibility for eligible claims.
MV devices and the MV app do not collect usage telemetry. Review clinical fit, the monitoring setup, provider eligibility, patient costs and payer rules before enrollment. Reimbursement is not guaranteed.
One clinic or a wider network
For clinic groups, agree a focused first implementation with clinical and operational leads. Expand on the basis of patient experience, practical fit and an honest review of the results.
Before introduction
Before expansion
Bring the information into your team meeting
Use original sources for the evidence review and the correct model guide for practical instruction.
The clinical evidence PDF, devices brochure and pelvic-health leaflets in one place.
Setup, cleaning, care and safety information, with a product-support route.
Original clinician videos for discussion and professional education.
Model-specific regulatory context to review alongside research and patient suitability.
Questions from pelvic-health teams
Practical answers for therapists, clinical leads and the team arranging patient access.
The studies summarized here examine sexual function, pain-related outcomes and adjunct use. They do not establish muscle strengthening, biofeedback, or treatment of prolapse or incontinence. Match the exact model and its intended use to the patient’s clinical needs; do not infer a pelvic-floor treatment claim from a sexual-function result.
No. The controlled pilot evaluated external Poco use alongside usual care that included vaginal dilators and psychosexual resources. It was designed primarily around acceptability and feasibility. Its findings should not be presented as evidence that a device replaces dilators, therapeutic exercise or the wider treatment plan.
Molto adds a slim, bendable profile when a patient prefers a narrower form factor. That is a fit consideration, not evidence that it treats pelvic-floor dysfunction. Review its exact-model instructions and intended use, rather than transferring findings from Poco or Crescendo to Molto.
No. A device does not make a session eligible for a particular therapy code. The code must describe the clinically appropriate service actually provided, with the required documentation and payer conditions. Have your coding team review the proposed workflow. Any device sale and optional RTM service are separate questions; no universal reimbursement or profit figure applies.
The correct model guide, the agreed individual plan, cleaning and safety instructions, and clear contacts for clinical questions and product support. Discuss comfort, practical handling and follow-up. Do not assume that a study’s schedule is suitable for every patient or that device use is automatically recorded for your clinic.
Tell us your care setting, clinical lead, locations, models of interest and preferred purchasing route. Request current pricing, availability and product resources, then agree staff preparation and support responsibilities. Please keep identifiable patient information out of your enquiry.
Start with your patients and your practice
Bring your clinical questions and preferred way of working. We can help your team find the relevant device information, evidence and purchasing resources for a focused first review.
